Search - tctmd.com

Displaying 1 - 20 of 22

Sort: Relevancy | Date

Presentation THT Abstracts 2026

Heart Failure with Hematologic Malignancy: Increasing Hospitalizations and Worsening Outcomes in the Modern Era

Presenter: Nithila Sivakumar

March 02, 2026

Presentation THT Abstracts 2026

Heart Failure Hospitalizations and Mortality Across the Body Mass Index Spectrum in Patients with Implanted Pulmonary Artery Pressure Sensors

Presenter: D Kalil

March 02, 2026

Presentation THT Abstracts 2026

A Retrospective Analysis of Heart Failure Hospitalization Trends in Patients with Functional Mitral Regurgitation in a Real-world Clinical Setting

Presenter: Colin Barker

March 02, 2026

Presentation THT Abstracts 2026

Impact of Baroreflex Activation Therapy on Hospitalizations: A Single Center Retrospective analysis

Presenter: Joel Joseph

March 02, 2026

Presentation THT Abstracts 2026

Outcomes and Risk Factors Among Hospitalizations Requiring Temporary Mechanical Circulatory Support for Cardiogenic Shock

Presenter: Omaima Chaudhary

March 02, 2026

Presentation THT Abstracts 2026

Sex Differences in Utilization of Temporary Mechanical Circulatory Support Among Heart Failure Hospitalizations in the United States

Presenter: Omaima Chaudhary

March 02, 2026

Presentation THT 2025

Subcutaneously Implanted Sensor for Remote Monitoring of Congestive Heart Failure Enables Effortless Capture of Electrocardiography and Three-Axis Acceleration Traces (ECG/SCG) Before and After Hospitalization: First Trend Results in Patients

Presenter: Marat Fudim

February 13, 2025

Presentation THT 2025

Bioelectrical Phase Angle for Heart Failure (HF) Hospitalization and Readmission Risk Stratification

Presenter: Kivanc Ozonat

February 12, 2025

Presentation THT 2025

Impact of Prior Heart Failure Hospitalizations on Long-Term Outcomes Following ICD Implantation and Generator Exchange

Presenter: Midori Torpoco Rivera

February 12, 2025

Presentation THT 2025

Initial Diuretic Strategies and Heart Failure Hospitalization Outcomes: Insights From a Nationwide Community-Based Cohort

Presenter: Anubodh Varshney

February 12, 2025

Presentation THT 2025

Pulmonary Artery Diastolic Pressure Is Lower in Women Than Men Preceding and at the Time of Heart Failure Hospitalization

Presenter: JoAnn Lindenfeld

February 12, 2025

Presentation THT Abstracts 2025

Bioelectrical Phase Angle for Heart Failure (HF) Hospitalization and Readmission Risk Stratification

Presenter: Kivanc Ozonat

February 11, 2025

Presentation TCT 2024

TCT 625: A Lower Ratio of Regurgitant Volume to Left Atrium Volume Is Associated With a Higher Incidence of Heart Failure Hospitalization in Patients With Ventricular Functional Mitral Regurgitation Undergoing Transcatheter Edge-to-Edge Repair

Presenter: Masafumi Yoshikawa

October 28, 2024

Presentation THT 2024

Remote Management of Sitting Pulmonary Artery Pressures Tested Against a Performance Goal of Reduced HF Hospitalizations and All-cause Mortality in a Prospective Multi-Center Open Label PROACTIVE-HF Trial in NYHA Class III Heart Failure

Presenter: Liviu Klein

March 05, 2024

Presentation THT 2024

Future HF Trials Should Focus on Patients in the High-Risk Period After an ADHF Hospitalization

Presenter: Gad Cotter

March 04, 2024

$Hierarchical composite endpoints for heart failure trials - answering the question: What fraction of the composite endpoint is due to cardiovascular mortality, hospitalization, or quality of life?$

Presentation THT 2023

Hierarchical composite endpoints for heart failure trials - answering the question: What fraction of the composite endpoint is due to cardiovascular mortality, hospitalization, or quality of life?

Presenter: Michael Sutherland

March 21, 2023

Presentation THT 2023

Cardiovascular Hospitalization Rates in ATTR-CA: What Factors Make a Difference

Presenter: Margaret Cuomo

March 21, 2023

Presentation THT 2023

What are the Strengths and Limitations of a Two-Phase (6-Month Intermediate Endpoints & 12-18 Month Mortality and Heart Failure Hospitalization) Trial Design

Presenter: William Abraham

March 20, 2023

Presentation THT 2022

Efficacy of Hemodynamic-Guided Heart Failure Management in Patients Enrolled With Elevated Natriuretic Peptide Levels but Without a Recent HF Hospitalization: An Analysis of the GUIDE-HF Trial

Presenter: Akshay Desai

February 02, 2022

Presentation THT 2022

SCAI Stage Across Hospitalization and the Association of Time to Max Escalation and In-hospital Mortality Among Cardiogenic Shock Patients

Presenter: Shashank Sinha

February 02, 2022

Advertisement

Heart Failure with Hematologic Malignancy: Increasing Hospitalizations and Worsening Outcomes in the Modern Era

Heart Failure Hospitalizations and Mortality Across the Body Mass Index Spectrum in Patients with Implanted Pulmonary Artery Pressure Sensors

A Retrospective Analysis of Heart Failure Hospitalization Trends in Patients with Functional Mitral Regurgitation in a Real-world Clinical Setting

Impact of Baroreflex Activation Therapy on Hospitalizations: A Single Center Retrospective analysis

Outcomes and Risk Factors Among Hospitalizations Requiring Temporary Mechanical Circulatory Support for Cardiogenic Shock

Sex Differences in Utilization of Temporary Mechanical Circulatory Support Among Heart Failure Hospitalizations in the United States

Subcutaneously Implanted Sensor for Remote Monitoring of Congestive Heart Failure Enables Effortless Capture of Electrocardiography and Three-Axis Acceleration Traces (ECG/SCG) Before and After Hospitalization: First Trend Results in Patients

Bioelectrical Phase Angle for Heart Failure (HF) Hospitalization and Readmission Risk Stratification

Impact of Prior Heart Failure Hospitalizations on Long-Term Outcomes Following ICD Implantation and Generator Exchange

Initial Diuretic Strategies and Heart Failure Hospitalization Outcomes: Insights From a Nationwide Community-Based Cohort

Pulmonary Artery Diastolic Pressure Is Lower in Women Than Men Preceding and at the Time of Heart Failure Hospitalization

Bioelectrical Phase Angle for Heart Failure (HF) Hospitalization and Readmission Risk Stratification

TCT 625: A Lower Ratio of Regurgitant Volume to Left Atrium Volume Is Associated With a Higher Incidence of Heart Failure Hospitalization in Patients With Ventricular Functional Mitral Regurgitation Undergoing Transcatheter Edge-to-Edge Repair

Remote Management of Sitting Pulmonary Artery Pressures Tested Against a Performance Goal of Reduced HF Hospitalizations and All-cause Mortality in a Prospective Multi-Center Open Label PROACTIVE-HF Trial in NYHA Class III Heart Failure

Future HF Trials Should Focus on Patients in the High-Risk Period After an ADHF Hospitalization

Hierarchical composite endpoints for heart failure trials - answering the question: What fraction of the composite endpoint is due to cardiovascular mortality, hospitalization, or quality of life?

Cardiovascular Hospitalization Rates in ATTR-CA: What Factors Make a Difference

What are the Strengths and Limitations of a Two-Phase (6-Month Intermediate Endpoints & 12-18 Month Mortality and Heart Failure Hospitalization) Trial Design

Efficacy of Hemodynamic-Guided Heart Failure Management in Patients Enrolled With Elevated Natriuretic Peptide Levels but Without a Recent HF Hospitalization: An Analysis of the GUIDE-HF Trial

SCAI Stage Across Hospitalization and the Association of Time to Max Escalation and In-hospital Mortality Among Cardiogenic Shock Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content